Surgeon Howard N. Langstein joins the company to leverage his experience and help other surgeons optimize clinical outcomes in plastic & reconstructive surgery.
Trial is designed to assess the Clotild sensor's capability to detect various characteristics of blood vessel blockages in peripheral artery disease patients.